Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Accumulated Depreciation (2019 - 2025)

Historic Accumulated Depreciation for Revolution Medicines (RVMD) over the last 7 years, with Q3 2025 value amounting to $27.0 million.

  • Revolution Medicines' Accumulated Depreciation rose 2464.36% to $27.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.0 million, marking a year-over-year increase of 2464.36%. This contributed to the annual value of $21.8 million for FY2024, which is 2333.56% up from last year.
  • Latest data reveals that Revolution Medicines reported Accumulated Depreciation of $27.0 million as of Q3 2025, which was up 2464.36% from $25.0 million recorded in Q2 2025.
  • Revolution Medicines' Accumulated Depreciation's 5-year high stood at $27.0 million during Q3 2025, with a 5-year trough of $8.7 million in Q1 2021.
  • Moreover, its 5-year median value for Accumulated Depreciation was $16.8 million (2023), whereas its average is $16.7 million.
  • As far as peak fluctuations go, Revolution Medicines' Accumulated Depreciation surged by 4119.55% in 2021, and later surged by 1985.95% in 2024.
  • Quarter analysis of 5 years shows Revolution Medicines' Accumulated Depreciation stood at $10.8 million in 2021, then surged by 34.01% to $14.5 million in 2022, then grew by 22.12% to $17.7 million in 2023, then grew by 23.34% to $21.8 million in 2024, then increased by 23.79% to $27.0 million in 2025.
  • Its Accumulated Depreciation stands at $27.0 million for Q3 2025, versus $25.0 million for Q2 2025 and $23.4 million for Q1 2025.